Company Overview of Chroma Therapeutics Ltd.
Chroma Therapeutics Ltd., a biotechnology company, focuses on the discovery and development of novel small molecule drugs based on chromatin biology and novel cell accumulation approaches for targeted cancer and inflammation treatments. Its products under pipeline include Tosedostat, an oral aminopeptidase inhibitor; CHR-3996, an optimized histone deacetylase inhibitor for the treatment of cancer; and CHR-2845, a targeted solution for haemotological malignancies. The company was founded in 2000 and is based in Abingdon, United Kingdom.
93 Innovation Drive
Abingdon, OX14 4RZ
Founded in 2000
44 1235 829120
44 1235 829125
Key Executives for Chroma Therapeutics Ltd.
Similar Private Companies By Industry
|Achilles Therapeutics Ltd.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Chroma Therapeutics Ltd., please visit www.chromatherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.